Neovacs Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-32.91	-8.74	-3.55	-11.84	-6.14	Upgrade
Depreciation & Amortization	0.19	0.16	0.15	0.1	0.06	Upgrade
Loss (Gain) From Sale of Assets	1.43	0.25	0	0.18	-	Upgrade
Asset Writedown & Restructuring Costs	6.75	4.85	0.32	0	-	Upgrade
Other Operating Activities	21.48	-	-	-0.11	0.13	Upgrade
Change in Other Net Operating Assets	-0.54	1.56	-1.37	1.76	0.31	Upgrade
Operating Cash Flow	-3.6	-1.91	-4.45	-9.91	-5.65	Upgrade
Capital Expenditures	-0.08	-0.2	-0.15	-0.35	-0.21	Upgrade
Sale (Purchase) of Intangibles	-	-0	-0	-0	-	Upgrade
Investment in Securities	1.53	-10.87	-31.4	-18.46	-0.02	Upgrade
Other Investing Activities	0	-0	-	-	-	Upgrade
Investing Cash Flow	1.45	-11.08	-31.56	-18.81	-0.22	Upgrade
Long-Term Debt Issued	1.09	6.19	9	46.85	14	Upgrade
Long-Term Debt Repaid	-1.52	-5.05	-8.83	-46.16	-13.76	Upgrade
Net Debt Issued (Repaid)	-0.43	1.14	0.17	0.69	0.24	Upgrade
Issuance of Common Stock	2.17	5.65	9.81	51.06	14.41	Upgrade
Other Financing Activities	-0.03	-	-	-	-	Upgrade
Financing Cash Flow	1.7	6.79	9.99	51.75	14.65	Upgrade
Miscellaneous Cash Flow Adjustments	-	-0	0	-	0	Upgrade
Net Cash Flow	-0.45	-6.2	-26.02	23.03	8.78	Upgrade
Free Cash Flow	-3.68	-2.12	-4.6	-10.26	-5.86	Upgrade
Free Cash Flow Margin	-848.26%	-396.80%	-413782.37%	-45498.69%	-19665.26%	Upgrade
Free Cash Flow Per Share	-21.09	-	-	-	-0.01	Upgrade
Levered Free Cash Flow	-2.59	-5.29	-3.5	-3.7	-2.05	Upgrade
Unlevered Free Cash Flow	-2.59	-5.29	-3.5	-3.7	-2.05	Upgrade
Change in Net Working Capital	-1.43	0.93	-0.54	-1.44	-0.28	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.